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Abstract
Introduction The incidence of breast cancer in the unaffected
breast of women with previous breast malignancy remains
constant after the first diagnosis. We investigated whether there
is a similar pattern in the breast cancer incidence in first-degree
relatives of breast cancer patients. We studied the risk for
breast cancer in mothers at ages older than their daughter's age
at diagnosis.
Methods We analyzed a Swedish population-based cohort with
complete family links and calculated incidence rates of breast
cancer in mothers of 48,259 daughters diagnosed with breast
cancer.
Results The risk for breast cancer in mothers of breast cancer
patients is elevated relative to the background population at all
ages. Mothers have an overall incidence of 0.34%/year at ages
older than a daughter's age at diagnosis. This rate is not affected
to any large extent by the daughter's age at diagnosis. A
constant incidence rate of 0.40%/year from age 35 years
onward is seen in mothers of breast cancer patients diagnosed
before 35 years of age. For mothers of daughters diagnosed at
age 35 to 44 years the incidence pattern is less clear, with the
rate being stable for approximately 20 years after the daughter's
age at diagnosis and rising thereafter. Older age at a daughter's
diagnosis (≥ 45 years) appears to confer an age-dependent
increase in incidence in the mother.
Conclusions Incidence of familial breast cancer in first-degree
relatives may increase to a high and constant level by a
predetermined age that is specific to each family. This
phenomenon appears inconsistent with accepted theories of
malignant transformation.
Introduction
Studies of familial aggregation of breast cancer identify a fam-
ily history of breast cancer as one of the strongest risk factors
for the disease [1,2]. Familial risks for female breast cancer
have been the subject of numerous epidemiological studies
[3-7]. A study that re-analyzed 52 epidemiological studies of
familial breast cancer presented summary risk ratios of 1.80
and 2.93 for one and two affected first-degree relatives,
respectively [8].
Young age at onset of disease within a family has long been
regarded as a particularly strong risk factor for breast cancer
[9-11]. Several studies have investigated the familial risk for
breast cancer in relation to both the proband's age at diagno-
sis and the age of the person at risk [3,12]. The results are sim-
ilar, regardless of whether siblings or mother/daughter pairs
are studied, and show that breast cancer risk in first-degree
relatives of breast cancer patients decreases with both the
age at diagnosis of the affected relative and the age of the per-
son at risk [3,13]. However, it is not known whether young age
in affected relatives only serves as a proxy for increased
genetic risk or whether it is a unique indicator of age at onset
in individual families.
Few studies have assessed the risk for disease on the abso-
lute scale. Peto and coworkers [10] suggested that there is a
family-specific age of onset and that the risk for breast cancer
is age independent thereafter in the family members. This
hypothesis contradicts most theories of malignant transforma-
tion, in which an age-dependent accumulation of genetic
events is proposed. The study was not population based and
had limited statistical precision because of small sample sizes
[10]. A similar constant risk with increasing follow up has been
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also appears to be present in twin sisters of breast cancer
patients, in whom the constant risk was observed in both
monozygotic and dizygotic female twin pairs [10,17].
We conducted a population-based study to characterize the
rate of breast cancer in first-degree relatives at ages older than
the index patient's age at diagnosis. In order to obtain a good
age range for our study, we examined the risk for breast cancer
in mothers of breast cancer patients.
Materials and methods
Data
The Multi-Generation Register includes all Swedish residents
born after 1931, who were alive in 1960, and all those born
thereafter. It contains links between children and parents
through their national registration numbers, which are
assigned to all residents in Sweden. The register is updated
yearly. During the period from 1961 to 2004 the complete-
ness of the Multi-Generation Register became progressively
better, and since 1991 it has been considered complete [18].
Approximately 40% of offspring who died before 1991 do not
have links to their mothers.
Information on cancer was obtained from the nationwide
Swedish Cancer Register, established in 1958. During the
period of our study, the Cancer Register was estimated to be
at least 98% complete [19]. For each notified cancer, the Can-
cer Register records the national registration number, ICD
(International Classification of Diseases) code, date of diagno-
sis and other details. Further record linkages to the nationwide
Cause of Death and Total Population Registers allowed com-
plete follow up with regard to vital status and date of death, as
well as dates of emigration and immigration.
From a total population cohort comprising about 11 million
individuals recorded in the Multi-Generation Register, we iden-
tified all women born in Sweden since 1932 with a first primary
invasive breast cancer diagnosed during the period from 1961
to 2004. Subsequently, we identified all the mothers of these
women, resulting in a total of 48,259 mother/daughter pairs in
which the daughter had a breast cancer diagnosis. In cases in
which more than one daughter from the same family had
breast cancer, we randomly selected one of the mother/
daughter pairs for inclusion in the study.
The ethics committees of the Karolinska Institute (Stockholm,
Sweden) approved the study.
Statistical analyses
Age-specific incidence rates in mothers of daughters with
breast cancer were calculated using 5-year intervals. Mothers
were studied up to age 85 years, and daughters could be
studied up to age 73 years (born after 1931). For the analysis
of complete follow up, person-years at risk began at the birth
of the mother or 1 January 1961, whichever came later, inde-
pendent of daughter's diagnosis. Mothers were followed only
from the age at diagnosis of breast cancer in their daughter in
order to estimate the incidence in mothers at ages older than
their daughter's age at diagnosis. Person-years at risk ended
on the date of diagnosis of a breast cancer, diagnosis of
another malignant cancer, death, emigration or the closing
date of the study (31 December 2004), whichever came first.
Age-specific breast cancer risk in the general Swedish popu-
lation (used for comparison) was estimated from the incidence
of breast cancers in mothers from our database. The 'general
population' was selected to be comparable to the mothers
with affected daughters in terms of year of birth (1887 to
1961).
Poisson regression was used to model the incidence of breast
cancer in mothers for each 5-year age category. Rates were
adjusted for calendar period in 5-year intervals. Likelihood ratio
was used to obtain the P value of the test for linear trends in
rates by maternal age categories. To investigate whether there
is heterogeneity in linear trends of the rates in mothers that are
approaching or have already passed the age at diagnosis of
their daughters, we split the exposure time of mothers into two
periods depending on whether the current age is younger or
older than the age at diagnosis of the daughter. We then
added to the previous model an interaction term between
maternal age and this new variable (before/after). Likelihood
ratio was used to obtain the P value of the heterogeneity in the
trend estimates. In the same manner we tested heterogeneity
in the trend estimates for mothers by age at diagnosis in
daughters. All data preparation and analysis was done using
the SAS statistical package, version 8.2 or higher (SAS Insti-
tute Inc., Cary, NC, USA) [20].
Results
We identified 48,259 daughters with breast cancer, 3,850 of
whom had mothers diagnosed with the same disease. In Fig-
ure 1 we present the age-specific incidence rates of breast
cancer in mothers stratified by daughter age at diagnosis. The
trends in rates of breast cancer had a different pattern in moth-
ers who are approaching and who have already reached the
age at diagnosis in their daughter (P  = 0.0248). Mothers
whose daughters were diagnosed before age 35 years had an
increasing risk for disease up to the age of diagnosis in the
daughter, and the risk remained roughly constant thereafter.
Such a trend was not observed for older ages at diagnosis in
the daughters. The mothers of daughters with breast cancer
continued to be at increased risk (even at ages of 80 to 84
years) compared with women in the general population (Figure
1).
In Table 1 we present the age-specific incidence rates in
mothers at ages older than their daughters' age at breast can-
cer diagnosis. The overall incidence of breast cancer in moth-
ers after the age of diagnosis in the daughters was 0.34%/
year. The risk was similar in the strata defined by the daugh-Available online http://breast-cancer-research.com/content/11/3/R30
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ter's age at diagnosis: 0.40%/year at age <35 years, 0.34%/
year at age 35 to 44 years, 0.33%/year at age 45 to 54 years,
and 0.35%/year at age 55 years or older.
In our analyses of the age-specific incidence rates in mothers
who have already reached the age at diagnosis in their daugh-
ters (Table 1), we found evidence of heterogeneity for age at
diagnosis in daughters (P = 0.0002). Mothers of patients with
a breast cancer diagnosis at age under 35 years exhibited a
high and constant risk of about 0.40%/year at ages older than
their daughters' age at breast cancer diagnosis. No increase
in incidence rates by age was seen in this group of mothers,
even after adjusting for calendar period using a Poisson model
(P for trend = 0.32). Mothers with daughters diagnosed at age
35 to 44 years had a risk that appeared to be constant for
approximately 20 years after the age at breast cancer diagno-
sis in their daughter and increased afterward. However, there
was no significant difference in trend estimates for these two
follow-up intervals (P = 0.44). Finally, incidence rates in moth-
ers of daughters diagnosed at age 45 years or older increased
Figure 1
Age-specific incidence rates (with standard errors) of breast cancer in mothers of breast cancer patients Age-specific incidence rates (with standard errors) of breast cancer in mothers of breast cancer patients. Complete follow-up in mothers stratified by 
daughter's age at diagnosis: (a) 25 to 34 years; (b) 35 to 44 years; (c) 45 to 54 years; and (d) 55 to 64 years. Incidence rates of breast cancer in 
the general population during the period from 1961 to 2004 are included for comparison. Arrows indicate the age group of the mothers that had 
already attained the age at diagnosis in their daughters.Breast Cancer Research    Vol 11 No 3    Czene et al.
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Table 1
Age-specific incidence rates of breast cancer
Age of mothers (years) Cases (n) IR (95%CI)a
Daughter age at diagnosis <35
<40 23 0.40 (0.25–0.60)
40–44 23 0.36 (0.23–0.54)
45–49 28 0.38 (0.25–0.55)
50–54 32 0.43 (0.29–0.60)
55–59 30 0.42 (0.28–0.60)
60–64 22 0.42 (0.26–0.64)
65–69 25 0.43 (0.28–0.63)
70–74 14 0.39 (0.21–0.65)
75–79 8 0.34 (0.14–0.64)
80–84 6 0.43 (0.16–0.94)
All ages 211 0.40 (0.35–0.46)
Increase in IR per 5-year age categoryb 0.97 (0.90–1–04)
Test for linear trendb P = 0.32
Daughter age at diagnosis 35 to 44
40–44 21 0.27 (0.19–0.38)
45–49 91 0.29 (0.23–0.36)
50–54 105 0.30 (0.25–0.36)
55–59 100 0.28 (0.22–0.34)
60–64 116 0.33 (0.27–0.40)
65–69 125 0.40 (0.34–0.48)
70–74 108 0.44 (0.36–0.53)
75–79 75 0.43 (0.34–0.54)
80–84 46 0.44 (0.33–0.59)
All ages 787 0.34 (0.32–0.37)
Increase in IR per 5-year age categoryb 1.03 (0.98–1.07)
Test for linear trendb P = 0.11
Age at diagnosis in daughters 45–54
50–54 75 0.23 (0.18–0.29)
55–59 165 0.23 (0.20–0.27)
60–64 212 0.29 (0.25–0.33)
65–69 272 0.40 (0.35–0.45)
70–74 226 0.38 (0.33–0.43)
75–79 181 0.39 (0.33–0.45)
80–84 140 0.47 (0.39–0.55)
All ages 1,271 0.33 (0.31–0.35)
Increase in IR per 5-year age categoryb 1.06 (1.02–1.11)
Test for linear trendb P = 0.003Available online http://breast-cancer-research.com/content/11/3/R30
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steadily with age, with a significant trend (P  < 0.05) after
adjusting for calendar period.
Discussion
Mothers of breast cancer patients are at increased risk for dis-
ease throughout the course of their life in comparison with the
background population. At ages older than a daughter's age at
diagnosis, her mother has an overall incidence that is not
affected to any large extent by the age at diagnosis of her
daughter. Mothers of breast cancer patients diagnosed at a
young age are at high and constant risk from that age onward.
We recognize that it is counterintuitive to consider breast can-
cer risk in mothers based on future breast cancer diagnosis in
their daughters. However, we believe that the two individuals
are interchangeable when discussing risk for breast cancer,
primarily because the risk in daughters by mother and vice
versa are similar [3,12]. We also believe that the latent period
between their diagnoses does not invalidate the comparison.
The strength of our study is in the prospective population-
based design, large sample size, completeness of follow up
and unbiased information on family history. Incidence rates for
the general population are based on our database and are sim-
ilar to the rates based on the Swedish Cancer Register [21].
Although it would be more intuitive to study the risk for breast
cancer in daughters or sisters of affected women, both of
these analyses are subject to serious confounding between
age and calendar date because of limitations in the data. Since
the index women in our Multi-Generation Register were born
after 1932, we could follow daughters only to a maximum age
of 73 years, and any cancer in the oldest age group could only
be diagnosed during the final years of follow up. As a result, it
Age at diagnosis in daughters ≥55
60–64 77 0.25 (0.20–0.31)
65–69 169 0.35 (0.30–0.40)
70–74 184 0.35 (0.30–0.41)
75–79 156 0.35 (0.30–0.41)
80–84 147 0.45 (0.38–0.53)
All ages 733 0.35 (0.33–0.38)
Increase in IR per 5-year age categoryb 1.09 (1.01–1.17)
Test for linear trendb P = 0.02
All ages at diagnosis in daughters
<40 23 0.40 (0.25–0.60)
40–44 44 0.27 (0.20–0.36)
45–49 119 0.31 (0.26–0.37)
50–54 212 0.28 (0.25–0.32)
55–59 295 0.26 (0.23–0.29)
60–64 427 0.30 (0.27–0.33)
65–69 591 0.38 (0.35–0.42)
70–74 532 0.38 (0.35–0.41)
75–79 420 0.38 (0.34–0.42)
80–84 339 0.46 (0.41–0.51)
All ages 3,002 0.34 (0.33–0.36)
Increase in IR per 5-year age categoryb 1.02 (1.00–1.04)
Test for linear trendb P = 0.03
Heterogeneityc P = 0.0002
Shown are the age-specific incidence rates (IRs) of breast cancer in 48,259 mothers followed after age at diagnosis in daughters in Sweden: 
1961 to 2004. aIncidence rate in percentage per year (unadjusted), with 95% confidence intervals (CIs). bPoisson regression model; rates were 
adjusted for calendar period in 5-year intervals. cHeterogeneity in the trend estimates for mothers by age at diagnosis in daughters.
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would be possible to begin follow up in sisters of older women
only in recent years, again confounding calendar date and age.
By studying the risk in mothers, not only can we follow women
at all ages beyond the age at diagnosis of their relative (daugh-
ter), but also the diagnoses are evenly spread over the study
period, with all ages represented in all years, allowing us to
control for confounding by calendar date. Some mothers have
been censored from our analyses, because the mothers could
not be identified for 40% of women who died before 1991.
However, we have shown elsewhere [22] that there is no bias
from missing family links, except when there is a very large dif-
ference in mortality between familial and nonfamilial cases.
Unilateral breast cancer rates are highly age dependent, being
a rare event at young ages and more common as age
advances, particularly after the menopause [23,24]. Our anal-
ysis of mother/daughter pairs reveals an overall incidence that
is apparently independent of the probands' age at diagnosis
(0.34%/year). Previous studies of the absolute risk for breast
cancer in women stratified by the age of their relative have
yielded similar results [10].
The most intriguing finding is the constant risk for breast can-
cer in mothers who have already attained the age of the index
diagnosis in their family. This pattern was seen for mothers of
breast cancer patients diagnosed before 35 years of age, with
a constant rate for the whole follow-up period (Table 1). For
mothers of daughters diagnosed at age 35 to 44 years the pat-
tern was less apparent, with a rate that appeared to be con-
stant for approximately 20 years after the daughter's age at
diagnosis and rising thereafter. This pattern was not seen for
older age at diagnosis (≥ 45 years) in daughters. The small
sample size of the youngest age stratum (daughters <35
years) may result in our having missed a significant trend
because of inadequate power. However, the 95% confidence
interval (0.90 to 1.04) allows us to exclude confidently an
effect of the magnitude found in other age groups and to con-
clude that the trend – if any – can only be of very small magni-
tude. One interpretation of our findings could be that in
families with a older age at onset the familial cancers are
'diluted', with sporadic cases inducing a less pronounced pat-
tern in terms of age at diagnosis.
An age-independent model of familial breast cancer risk at
ages older than the proband's age at diagnosis was previously
proposed by Peto and coworkers [10]. Those investigators
suggested that the absolute breast cancer risk increases to a
high and constant level by a predetermined age that is specific
to each family. A similar constant risk with increasing follow up
has been observed for contralateral breast cancer, in which
the risk for the second cancer is not modified by age and has
a constant rate of 0.5%/year [14-16]. This pattern also
appears to be present in twin sisters of breast cancer patients;
constant risk was observed in both mono and dizygotic female
twin pairs [10,17]. This constant hazard could be interpreted
as a consequence of an accumulation of a sufficient number
of mutations at a certain point in time, resulting in a group with
an increased risk for either yet another cancer in the contralat-
eral breast or a first cancer in a first-degree relative. A constant
rate for female family members would suggest a similar accu-
mulated predisposition for the disease at a particular unique
family-specific age.
The vast majority of familial disease is associated with a low
penetrant polygenic aetiology that conveys lifetime risks some-
where below 30%, and only a small proportion are carriers of
the highly penetrant mutations of BRCA1 or BRCA2, in whom
the lifetime risks are quite substantial [4,25-28]. Thus far, it has
not been possible to establish a risk profile that would warrant
prophylactic measures because an insufficient number of
these low penetrance variants has been identified. This leaves
us with the issue of when to start screening the high-risk pop-
ulations, especially those who have a relative diagnosed at a
young age. Our data indicate a reasonably small risk at ages
younger than the proband's age at diagnosis for women with
a proband diagnosed at age under 35 years, but we observe
a high and constant risk from that age onward. A reasonable
interpretation would then be to start screening at least a few
years before the proband's age at diagnosis; 5 years before
would generate a buffer zone to avoid missed disease in this
age category.
Conclusions
The observed patterns of familial rates of breast cancer sug-
gest that age at onset might be inherited while the sporadic
cancers dilute the message by superimposing a background
risk in families where cancers are detected at older ages. This
phenomenon seems inconsistent with accepted models of
susceptibility and has implications for the carcinogenic proc-
ess of breast cancer. Our findings suggest that screening of
unaffected first-degree relatives should start at an age younger
than the index patient's age at diagnosis. In the future we will
probably be able to identify nonsporadic cancers, and it will
become possible to direct screening activities toward these
women.
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